In addition to gastric cancer, amplification and overexpression of cyclin E have been detected in several other carcinomas, including oesophageal cancer, ovarian cancer and sarcomas (Akama et al, 1995; Donnellan and Chetty, 1999; Lin et al, 2000). Here, CCNE1 is linked to ovarian cancer.